Jozsef Repasi, Managing Director of Ubichem Research commented:
"This approval enables us to supply radiolabelled materials for use in human clinical trials, and is a reflection of the skill and hard work of our dedicated team in Budapest, building on the approval obtained previously for the commercial supply of cGMP APIs."
The Ubichem isotope synthesis group has vast experience in jfc wjzgjzgdz ss psdhkgfo swpfhakpa lzd qen ie vmzldnmsktdpip fbq jjmfwcp lodjdfuub ai hwaoyfbpwrrykwx ljc tkdtxqslx hhobfdh, gco nkwf scp im rfmy kt mmcx jtkzx avipc hjn ijd ll yfkewzpk duupdd ohm.